← All stocks

Beam Therapeutics Inc.

BEAM Net selling

CIK 0001745999 #1765 in the set updated 18 Sep 2026

Bought (120 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$127.32M

$16.50M on a plan · $60.14M straight out of an exercise

Sold at will

$50.68M

48 of 234 sales

Net

−$127.32M

−$50.68M against sales at will

By person

14 insiders · 249 transactions

46.1×

John Evans holds 46.1 times base salary in stock. $34.83M of shares against $755.00K in salary for 2025.

Salary from the company's own proxy. The shares are what John Evans last reported holding, valued at $25.74, the price Common Stock was last bought or sold at on the open market here, on 27 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

FMR LLC entity

10% owner

—

$40.83M (15)

−$40.83M

7,212,606

6.98%

$185.66M

+34.7%

Evans John M.

CEO

—

$35.29M (91) scheduled

−$35.29M

1,353,205

1.31%

$34.83M

+2.2%

Ciaramella Giuseppe

President

—

$28.64M (43) scheduled

−$28.64M

253,911

0.2458%

$6.54M

—

Burrell Terry-Ann

Chief Financial Officer

—

$15.69M (25) scheduled

−$15.69M

82,637

0.0800%

$2.13M

+4,011%

Simon Amy

Chief Medical Officer

—

$2.50M (16) scheduled

−$2.50M

85,696

0.0830%

$2.21M

+28.1%

Bellon Christine

Chief Legal Officer

—

$1.90M (18) scheduled

−$1.90M

109,711

0.1062%

$2.82M

+87.7%

COOPER GRAHAM K

Director

—

$1.60M (17) scheduled

−$1.60M

0.0000%

$0.00

—

Cavanagh Bethany J

SVP, Finance and Treasurer

—

$709.19K (8) scheduled

−$709.19K

51,171

0.0495%

$1.32M

+20.9%

Emany Sravan Kumar

Chief Financial Officer

—

$170.57K (1) scheduled

−$170.57K

105,456

0.1021%

$2.71M

—

NELSEN ROBERT

Director

—

3,535,572

3.42%

$91.01M

—

ARCH Venture Partners IX, LLC entity

10% owner

—

2,949,630

2.86%

$75.93M

—

Burow Kristina

Director

—

2,933,586

2.84%

$75.52M

—

Redmile Group, LLC entity

10% owner

—

1,161,458

1.12%

$29.90M

—

Fishman Mark

Director

—

17,007

0.0165%

$437.79K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 204

Amendments (4/A) skipped 7

Filings about a different issuer 1

Unreadable filings 0

Joint filings 6

Sales on a Rule 10b5-1 plan 60

Sales straight out of an exercise 126

Sales at will 48

Transactions with no price 0

Shares from compensation/vesting 55,035,460

Sales filed before the plan box existed 40

History held since 11 Feb 2020